Skip to main content
Caplight Logo









Origin Sciences

Origin Sciences

Private
United KingdomHealthcare & Life Scienceshttps://www.originsciences.com/

Last Round

VC Round

Oct 21, 2014

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Origin Sciences is a medical technology company that develops diagnostic devices and tests for the detection and monitoring of gastrointestinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

gastrointestinal diagnosticsrectal mucus collectioncolorectal cancer screeningliquid biopsymedical devicegenomics laboratory servicesinflammatory bowel diseaseIBDmolecular analysisbioinformaticsnon-invasive diagnosticsprecision medicineclinical diagnosticsmulti-omics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origin Sciences Comparables

Compare Origin Sciences with similar companies based on industry and business-model similarity.

Origin Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Geneoscopy
74%
Cyted Health
72%
Guardant Health
61%

Origin Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 21, 2014

Key People

Founding team and executive leadership

Hugo Lywood

Chief Executive Officer

Executive Team

Andrew Page

Chief Technology Officer

Executive Team

Shane Hall

Chief Financial Officer

Executive Team

Jamie Yexley

Chief Operating Officer

Executive Team

Origin Sciences Investors

Notable investors and investment history

Origin Sciences investors
InvestorRounds
CSVE VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 99% MoM.

  • Aug 10, 2026

    Open roles increased to 7, 3.5x the trailing average.

Recent news

Latest coverage and updates

  • invests_into_assetsAug 19, 2026

    Origin Sciences Ltd. invested into assets: three new clinic rooms in Stafford, United Kingdom, Northern Europe, Europe on Jul 1st '25.

  • is_developingAug 11, 2026

    Origin Sciences Ltd. is developing test to detect colorectal cancer and high-risk polyps.

Origin Sciences Filings

Explore SEC and related filing metadata, where available.

Origin Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Origin Sciences's valuation, stock price, and market status.

Is Origin Sciences a public or private company?

Origin Sciences is a private company.

What is the current stock price of Origin Sciences?

Origin Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Origin Sciences worth (valuation)?

Valuation information for Origin Sciences is not publicly available.

Can I buy Origin Sciences stock?

Origin Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Origin Sciences's last funding round?

Origin Sciences's most recent funding round was VC Round on October 21, 2014.

Who are the main investors in Origin Sciences?

Key investors in Origin Sciences include CSVE Ventures.

Will Origin Sciences IPO soon?

No public IPO plans have been announced for Origin Sciences.

How can I track Origin Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Origin Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited Kingdom
Employee Range28
Year Founded2003
Last FundingOct 21, 2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?